Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Neoplasms 2Breast Neoplasms 2Rectal Neoplasms 1Motor Activity 1Lung Neoplasms 1Hodgkin Disease 1Digestive System Neoplasms 1Cognitive Dysfunction 1Cardiovascular Diseases 1Brain Neoplasms 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Physical Conditioning, Human × Clear all
NCT05184582 2025-09-22

Neo-ACT

Karolinska Institutet

Phase NA Recruiting
712 enrolled
Breast

Breast Neoplasms

NCT04586517 2022-11-02

Effect of Heavy-load Resistance Training During Chemotherapy on Muscle Cellular Outcomes

Uppsala University

Phase NA Unknown
40 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡